Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

NEA

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$24M
Portfolio companies 10
Rounds per year 1.22
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Exits 1
Key employees Soon

Areas of investment

  • Information Technology
  • Software
  • Medical
  • Internet
  • Artificial Intelligence

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bank Leumi Israel, Tel Aviv, Tel Aviv District
Ddguanhuai.com Beijing, Beijing, China
Diem Bioventures -
Dinama -
Education Sales Management Colorado, Littleton, United States
Emergent Medical Partners California, Portola Valley, United States
Frontier Finland, Helsinki, Southern Finland
GE Capital Real Estate -
GVC Capital Colorado, Greenwood Village, United States
Ingrasys -
Jochu Technology Hsinchu, Taiwan, Taiwan Province
L Catterton Europe France, Ile-de-France, Paris
NST Venture -
Purple Cow Brentwood, California, United States
RGM Capital Florida, Naples, United States
Scudder Kemper Investments -
Visual Interactive Investments, LLC -
Y Ventures California, Monrovia, United States
YMC Japan, Kyoto, Kyoto Prefecture

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Thunkable

Apps
Developer Tools
Mobile Apps
$30M08 Feb 2022 San Francisco, California, United States

Pair Eyewear

E-Commerce
Eyewear
Fashion
Retail
Wearables
$60M14 Dec 2021 New York, New York, United States

UNION

Hospitality
$24M09 Dec 2021 Austin, Texas, United States

Datafold

Analytics
Application Performance Management
Big Data
Business Intelligence
Cloud Data Services
Data Integration
Information Technology
Quality Assurance
Software
$20M09 Nov 2021 San Francisco, California, United States

Neural Magic

Artificial Intelligence
Information Technology
Machine Learning
Software
$30M05 Oct 2021 Massachusetts, United States

Spiras Health

Health Care
Hospital
Medical
$14M22 Jun 2021 Nashville, Tennessee, United States

Stablix

Biotechnology
Health Care
Medical
$63M03 Jun 2021 New York, New York, United States

Plasmic

Information Technology
Internet
Software
$4M01 May 2021 San Francisco, California, United States

Inventiva Pharma

Biopharma
Biotechnology
Clinical Trials
Medical
Medical Device
$17M07 Feb 2020 France, Bourgogne-Franche-Comté, France
News
858 Therapeutics Launches with Proven Team and $60 Million Series A Financing

– 858 Therapeutics has raised $60m in Series A financing.
– The round was led by founding investor Versant Ventures, with participation from NEA, Cormorant Asset Management and Logos Capital.
– 858 is a biotechnology company developing novel therapeutics for the treatment of cancer.
– The company’s lead program is a novel small molecule inhibitor of the PI3K/mTOR pathway that is being developed for the treatment of solid tumors that are resistant to existing therapies.
– The Series A proceeds will allow 858 to enter the clinic with its lead candidates that have potential to treat cancers that are resistant to current therapies.

Workera.ai Lands $16M Series A Financing

– Workera.ai, a precision upskilling platform, has closed a $16m Series A round.
– The round was led by NEA alongside existing investors Owl Ventures and AI Fund, as well as AI luminaries Richard Socher of AIX Ventures, Pieter Abbeel, Lake Dai and Mehran Sahami.
– This new infusion of capital will be used to accelerate product development and fuel the company’s go-to-market strategy.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent NEA?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: